Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Approaches To Therapy Escalation In T2D: A Cluster Randomized Control Trial (ATTACC)

NCT03813316 is registered in ClinicalTrials.gov with LMC Diabetes & Endocrinology Ltd. as lead sponsor.

NCT NCT03813316
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03813316 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Approaches To Therapy Escalation In T2D: A Cluster Randomized Control Trial (ATTACC)
Lead sponsor
LMC Diabetes & Endocrinology Ltd.
Phase
Phase 4
Overall status
Withdrawn
Start date
May 1, 2019
Completion date
September 18, 2019
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes